Multiple studies have shown that curbing TNF-α secretion in gliomas can effectively increase viral replication and spreads, thereby improving the anti-tumor effects in OV therapy (Meisen et al., 2015; Yoo et al., 2019). Here, TNF is linked to neoplasm.